Analytical Data
-
基因名
Slc17a6
- Application
-
别名
(VGluT2)(Differentiation-associated BNPI)(Differentiation-associated Na(+)(Solute carrier family 17 member 6)
-
种属
Rat
-
表达系统
Yeast
-
标签
C- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9JI12
-
表达区间
499-582aa
-
分子量
11.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human DPPA4 Protein，His
Cat：PA1000-917DB
Recombinant E.coli MHT1 Protein，His
Cat：PA2000-3665
Recombinant Human ENGASE Protein，His
Cat：PA1000-9540
Protein Description
The study of the Slc17a6 gene, also known as VGLUT2 (vesicular glutamate transporter 2), is crucial in understanding neurotransmission in the brain. This protein plays a significant role in the packaging of glutamate, the primary excitatory neurotransmitter, into synaptic vesicles, thus influencing synaptic signaling and plasticity. Dysregulation of Slc17a6 expression has been implicated in various neurological disorders, including epilepsy, schizophrenia, and depression. Researchers have sought to produce recombinant Slc17a6 protein to elucidate its structure and function at a molecular level. This recombinant protein enables a variety of biochemical assays and functional studies, providing insights into the transport mechanism and regulatory factors affecting glutamate signaling. Additionally, studying this protein can aid in identifying potential therapeutic targets for treating glutamate-related pathologies. Understanding the intricacies of Slc17a6's operation and its interaction with other proteins within the neural environment could pave the way for advances in neuropharmacology and ultimately improve treatment strategies for neuronal diseases.
